Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

Journal Article (Journal Article)

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.

Full Text

Duke Authors

Cited Authors

  • Tempero, MA; Malafa, MP; Behrman, SW; Benson, AB; Casper, ES; Chiorean, EG; Chung, V; Cohen, SJ; Czito, B; Engebretson, A; Feng, M; Hawkins, WG; Herman, J; Hoffman, JP; Ko, A; Komanduri, S; Koong, A; Lowy, AM; Ma, WW; Merchant, NB; Mulvihill, SJ; Muscarella, P; Nakakura, EK; Obando, J; Pitman, MB; Reddy, S; Sasson, AR; Thayer, SP; Weekes, CD; Wolff, RA; Wolpin, BM; Burns, JL; Freedman-Cass, DA

Published Date

  • August 2014

Published In

Volume / Issue

  • 12 / 8

Start / End Page

  • 1083 - 1093

PubMed ID

  • 25099441

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2014.0106


  • eng

Conference Location

  • United States